The Sweet Gatekeeper: Mucin-Type O-Glycans In Brain Endothelial Glycocalyx And Aging

Research indicates that a reduction in specific sugar molecules on the surface of brain blood vessels, known as mucin-type O-glycans, contributes to the weakening of the brain’s protective barrier, leading to increased inflammation and cognitive decline during aging and in neurodegenerative conditions.

Our brains are protected by a highly specialized “gatekeeper” called the blood-brain barrier, which carefully controls what enters and exits the brain. This barrier has a crucial, often overlooked, component: a delicate “sugar shield” known as the glycocalyx, which coats the blood vessels in the brain.

Recent findings highlight that this sugar shield, particularly a type of sugar modification called mucin-type O-glycans, undergoes significant changes as we age and in the presence of neurodegenerative diseases like Alzheimer’s. When these specific sugar molecules are reduced, the protective shield thins, making the blood-brain barrier “leaky.” This compromised barrier allows harmful substances to enter the brain, triggering inflammation and contributing to a decline in cognitive functions, such as memory and thinking.

Crucially, the research also demonstrated that by restoring these vital sugar molecules, the integrity of the blood-brain barrier can be improved. This restoration not only reduced brain inflammation but also led to better cognitive performance in aged subjects. These insights suggest a promising new avenue for developing treatments that could help maintain brain health and combat age-related cognitive decline by targeting and restoring this essential sugar shield.

---

Source: link to paper